Position in AMGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,093,963
+$7,451 QoQ
Shares Held
3,021
-2.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,642
of 3,140 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Analysts, LLC holds $29,659,281 across 14 Drug Manufacturers - General names. AMGN ranks #5 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
72,378 | $9,300,573 | |
| 2 | JNJ |
Johnson & Johnson
|
32,347 | $8,215,167 | |
| 3 | LLY |
ELI LILLY & Co
|
5,315 | $6,374,970 | |
| 4 | ABBV |
AbbVie Inc.
|
7,055 | $1,775,319 | |
| 5 | AMGN |
Amgen Inc
This page
|
3,021 | $1,093,963 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6,923 | $874,651 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
11,930 | $687,405 | |
| 8 | NVS |
Novartis AG
|
4,070 | $637,849 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,093,963 | 3,021 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $1,086,512 | 3,088 | Shares | Defined | 2026-05-14 | |
| 2025-09-30 | $724,125 | 2,566 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $691,044 | 2,475 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $769,839 | 2,471 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $485,050 | 1,861 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $608,976 | 1,890 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $580,218 | 1,857 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $487,892 | 1,716 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $490,209 | 1,702 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $461,729 | 1,718 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $354,564 | 1,597 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $383,898 | 1,588 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $389,232 | 1,482 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $359,061 | 1,593 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $382,467 | 1,572 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $379,173 | 1,568 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $363,101 | 1,614 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $364,056 | 1,712 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $381,712 | 1,566 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $2,357,723 | 9,476 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,796,824 | 7,815 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,875,954 | 7,381 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,649,133 | 6,992 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $1,464,926 | 7,226 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||